Retatrutide, a experimental dual activator of the GLP-1 receptor and glucose-dependent insulinotropic polypeptide (GIP) binding site , is exhibiting promising results in initial clinical trials . Ongoing https://zbookmarkhub.com/story21526967/retatrutide-emerging-studies-and-possible-therapeutic-applications